Activity-guided isolation of antileishmanial compounds from Piper hispidum

Phytochemistry Letters

Volumn 4, Issue 3, 2011, Pages 363-366

  Ruiz, Candy ^a   Haddad, Mohamed ^b,c   Alban, Joaquina ^d   Bourdy, Genevive ^b,c   Reategui, Ricardo ^a,e   Castillo, Denis ^a   Sauvain, Michel ^b,c   Deharo, Eric ^b,c   Estevez, Yannick ^b,c   Arevalo, Jorge ^a   Rojas, Rosario ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Peru)

^c UMR 152 IRD Universite Paul Sabatier   (France)

^d UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^e ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

Amide; Chalcone; Flavanone; Leishmaniasis; Piper

Indexed keywords

2' HYDROXY 3',4',6' TRIMETHOXYCHALCONE; 2',4' DIHYDROXY 6' METHOXYCHALCONE; AMIDE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; CHALCONE DERIVATIVE; N 2 (3',4',5' TRIMETHOXYPHENYL)ETHYL 2 HYDROXYBENZAMIDE; PINOCEMBRINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FRACTIONATION; IC 50; IN VITRO STUDY; LEISHMANIA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PERITONEUM MACROPHAGE; PIPER HISPIDUM; PIPERACEAE; PLANT LEAF; PRIORITY JOURNAL;

LEISHMANIA AMAZONENSIS; PIPER HISPIDUM;

EID: 80053322491     PISSN: 18743900     EISSN: 18767486     Source Type: Journal    
DOI: 10.1016/j.phytol.2011.08.001     Document Type: Article

References (28)

1. B.J. Cabanillas, A.C. Le Lamer, D. Castillo, J. Arevalo, R. Rojas, G. Odonne, G. Bourdy, B. Moukarzel, M. Sauvain, and N. Fabre Caffeic acid esters and lignans from Piper sanguineispicum J. Nat. Prod. 73 2010 1884 1890
2. A.K. Chava, M. Chatterjee, and C. Mandal K.J. Yarema, Handbook of Carbohydrate Engineering 2005 Taylor & Francis Boca Raton, FL 71 98
3. I.S. Chen, Y.C. Chen, and C.H. Liao Amides with anti-platelet aggregation activity from Piper taiwanense Fitoterapia 78 2007 414 419
4. A.J. Davis, H.W. Murray, and E. Handman Drug against leishmaniasis: a synergy of technology and partnerships Trends Parasitol. 20 2004 73 76 (Pubitemid 38121262)
5. A. Detsi, M. Majdalani, C.A. Kontogiorgis, D. Hadjipavlou-Litina, and P. Kefalas Natural and synthetic 20-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity Bioorg. Med. Chem. 17 2009 8073 8085
6. Y. Estevez, D. Castillo, T. Pisango, J. Arevalo, R. Rojas, J. Alban, E. Deharo, G. Bourdy, and M. Sauvain Evaluation of the leishmanicidal activity of plants used by Peruvian Chayahuita ethnic group J. Ethnopharmacol. 114 2007 254 259 (Pubitemid 47554611)
7. N. Flores, G. Cabrera, I.A. Jiménez, J. Piñero, A. Giménez, G. Bourdy, F. Cortés-Selva, and I.L. Bazzocchi Leishmanicidal constituents from the leaves of Piper rusbyi Planta Med. 73 2007 206 211 (Pubitemid 46917471)
8. P.J. Guerin, P. Olliaro, S. Sundar, M. Boelaert, S.L. Croft, P. Desjeux, M.K. Wasunna, and A.D. Brycerson Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda Lancet Infect. Dis. 2 2002 494 501 (Pubitemid 34826855)
9. A. Hermoso, I.A. Jiménez, Z.A. Mamani, I.L. Bazzocchi, J.E. Piñero, A.G. Ravelo, and B. Valladares Antileishmanial activities of dihydrochalcones from Piper elongatum and synthetic related compounds. Structural requirements for activity Bioorg. Med. Chem. 11 2003 3975 3980 (Pubitemid 36970124)
10. J.R. Ioset Natural products for neglected diseases: a review Curr. Org. Chem. 12 2008 643 666
11. T. Jaipetch, S. Kanghae, O. Pancharoen, V.A. Patrick, V. Reutrakul, P. Tuntiwachwuttikul, and A.H. White Constitutes of Boesenbergia pandurata. Synthesis of (+)-boesenbergin A Aust. J. Chem. 35 1982 351 361
12. K. Jenett-Siems, F.P. Mockenhaupt, U. Bienzle, M.P. Gupta, and E. Eich In vitro antiplasmodial activity of Central American medicinal plants Trop. Med. Int. Health 4 1999 611 615 (Pubitemid 29470217)
13. M. Kuroyanagi, T. Noro, S. Fukushima, R. Aiyama, A. Ikuta, H. Itokawa, and M. Morita Chem. Pharm. Bull. 31 1983 1544 1550
14. P.S. Luize, T. Ueda-Nakamura, B.P. Filho, G.D. Cortéz, and C.V. Nakamura Activity of neolignans isolated from Piper regnellii (MIQ.) C.DC. var. pallescens (C.DC.) YUNCK against Trypanosoma cruzi Biol. Pharm. Bull. 10 2006 2126 2130 (Pubitemid 44510822)
15. Y. Ma, G.Q. Han, C.L. Li, J.R. Cheng, B.H. Arison, and S.B. Hwang Neolignans from Piper polysyphorum C.DC. Yao Xue Xue Bao 26 1991 345 350
16. H.W. Murray, J.D. Berman, C.R. Davies, and N.G. Saravia Advances in leishmaniasis Lancet 366 2005 1561 1577 (Pubitemid 41540115)
17. J. Orjala, A.D. Wright, H. Behrends, G. Folkers, and O. Sticher Cytotoxic and antibacterial dihydrochalcones from Piper aduncum J. Nat. Prod. 57 1994 18 26 (Pubitemid 24076890)
18. V.S. Parmar, S.C. Jain, K.S. Bisht, R. Jain, P. Taneja, A. Jha, O.D. Tyagi, A.K. Prasad, J. Wengel, C.E. Olsen, and P.M. Boll Phytochemistry of the genus Piper Phytochemistry 46 1997 597 673 (Pubitemid 27483827)
19. F.J. Perez-Victoria, S. Castanys, and F. Gamarro Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug Antimicrob. Agents Chemother. 47 2003 2397 2403 (Pubitemid 36919436)
20. B. Portet, N. Fabre, V. Roumy, H. Gornitzka, G. Bourdy, S. Chevalley, M. Sauvain, A. Valentin, and C. Moulis Activity-guided isolation of antiplasmodial dihydrochalcones and flavanones from Piper hostmannianum var. Berbicense Phytochemistry 68 2007 1312 1320 (Pubitemid 46604825)
21. M.A. Quijano-Abril, R. Callejas-Posadas, and D.R. Miranda-Esquivel Areas of endemism and distribution patterns for neotropical Piper species (Piperaceae) J. Biogeogr. 33 2006 1266 1278 (Pubitemid 43876173)
22. T. Rukachaisirikul, P. Siriwattanakit, K. Sukcharoenphol, C. Wongvein, P. Ruttanaweang, P. Wongwattnavuch, and A. Suksamrarn Chemical constituents and bioactivity of Piper sarmentosum J. Ethnopharmacol. 93 2004 173 176 (Pubitemid 38962403)
23. M. Sauvain, J.P. Dedet, N. Kunesch, J. Poisson, P. Gayral, J.C. Gantier, and G. Kunesch In vitro and in vivo leishmanicidal activities of natural and synthethic quinoids Phytother. Res. 7 1993 167 171 (Pubitemid 23106472)
24. D. Sereno, and J.-L. Lemesre Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents Antimicrob. Agents Chemother. 41 1997 972 976 (Pubitemid 27194170)
25. J. Soto, J. Toledo, L. Valda, M. Balderrama, I. Rea, R. Parra, J. Ardiles, P. Soto, A. Gomez, F. Molleda, C. Fuentelsaz, G. Anders, H. Sindermann, J. Engel, and J. Berman Treatment of Bolivian mucosal leishmaniasis with miltefosine Clin. Infect. Dis. 44 2007 350 356 (Pubitemid 46147616)
26. E.C. Torres-Santos, D.L. Moreira, M.A.C. Kaplan, M.N. Meirelles, and B. Rossi-Bergman Selective effect of 2′,6′-dihydroxy-4′- methoxychalcone isolated from Piper aduncum on Leishamnia amazonensis Antimicrob. Agents Chemother. 43 1999 1234 1241 (Pubitemid 29214753)
27. P.C. Vieira, M.A. De Alvarenga, O.R. Gottlieb, and H.E. Gottlieb 4-Hexadecenylphenol and flavonoids from Piper hispidum Planta Med. 39 1980 153 156
28. V. Yardley, S.L. Croft, S. de Doncker, J.C. Dujardin, S. Koirala, S. Rijal, C. Miranda, A. Llanos-Cuentas, and F. Chappuis The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine Am. J. Trop. Med. Hyg. 73 2005 272 275 (Pubitemid 41278697)